import{j as e,r as c,F as ee,e as te,l as ie,f as se,g as ae}from"./react-vendor-B1d8dduC.js";import{c as f,B as y,C as j,a as w,b as k,d as S,e as R,E as ne}from"./module-cdu-BUS-kbPn.js";import{u as b,aq as P,au as O,av as re,C as oe,aw as le,ax as E,ay as ce,az as $,aA as U,aB as de,x as z,aC as me,aD as G,aE as ue,aF as pe,aG as W,aH as he,y as T,aI as _,aJ as ge,$ as A}from"./vendor-COw5p1kA.js";const F=[{id:"neutropenic-fever",title:"Neutropenic Fever",timeToAction:"60 minutes",category:["Hematologic","Infectious"],symptoms:["Fever (single temperature â‰¥38.3Â°C or â‰¥38.0Â°C sustained over 1 hour)","Absolute neutrophil count <500 cells/mmÂ³","Chills or rigors","Hypotension","Altered mental status"],diagnostics:["Complete blood count with differential","Blood cultures (2 sets, peripheral and central line if present)","Urine culture","Chest X-ray","Additional cultures from suspected sites of infection"],management:[{title:"Empiric Antibiotic Therapy",description:"Start broad-spectrum antibiotics within 1 hour of presentation"},{title:"Risk Assessment",description:"Determine high vs low risk based on MASCC score or CISNE index"},{title:"Source Control",description:"Remove infected catheters/devices if indicated"},{title:"Monitoring",description:"Close monitoring for clinical deterioration; ICU assessment if unstable"}],medications:[{name:"Piperacillin-Tazobactam",dosage:"4.5g IV every 6 hours"},{name:"Cefepime",dosage:"2g IV every 8 hours"},{name:"Meropenem",dosage:"1g IV every 8 hours"}],additionalNotes:"Consider antibiotic adjustments after 48-72 hours based on cultures and clinical response."},{id:"spinal-cord-compression",title:"Spinal Cord Compression",timeToAction:"12 hours",category:"Obstructive",symptoms:["Back pain (90% of cases)","Weakness or paralysis in extremities","Sensory loss below level of compression","Urinary or bowel incontinence/retention","Loss of deep tendon reflexes"],diagnostics:["MRI of entire spine (preferred)","CT scan if MRI contraindicated","Complete neurological examination","Laboratory tests: CBC, CMP, Calcium levels"],management:[{title:"High-Dose Corticosteroids",description:"Start dexamethasone immediately upon suspicion"},{title:"Urgent Neurosurgical/Radiation Oncology Consult",description:"Coordinate multidisciplinary care team"},{title:"Radiation Therapy",description:"External beam radiation therapy within 24 hours"},{title:"Surgical Decompression",description:"Consider for spinal instability or radioresistant tumors"}],medications:[{name:"Dexamethasone",dosage:"Loading dose: 10mg IV, then 4mg IV/PO every 6 hours"}]},{id:"tumor-lysis-syndrome",title:"Tumor Lysis Syndrome",timeToAction:"6 hours",category:"Metabolic",symptoms:["Hyperuricemia","Hyperkalemia","Hyperphosphatemia","Hypocalcemia","Acute kidney injury","Cardiac arrhythmias","Seizures"],diagnostics:["Serum electrolytes (K, Ca, P) q6h","Serum creatinine and BUN","Uric acid levels","Urine output monitoring","ECG monitoring for arrhythmias"],management:[{title:"Aggressive Hydration",description:"IV fluids at 2-3L/mÂ²/day to maintain high urine output (100-200 mL/h)"},{title:"Electrolyte Management",description:"Correct electrolyte imbalances; avoid calcium supplementation if phosphate is elevated"},{title:"Xanthine Oxidase Inhibitor",description:"Allopurinol for prevention; rasburicase for established hyperuricemia"},{title:"Renal Replacement",description:"Consider hemodialysis for severe electrolyte disturbances, oliguria, or azotemia"}],medications:[{name:"Allopurinol",dosage:"100-300mg PO every 8 hours"},{name:"Rasburicase",dosage:"0.2mg/kg IV as a single dose (use with caution in G6PD deficiency)"},{name:"Sodium Bicarbonate",dosage:"Consider for urinary alkalinization if pH <7.0"}],additionalNotes:"Avoid calcium correction until hyperphosphatemia is addressed to prevent calcium phosphate precipitation."},{id:"superior-vena-cava-syndrome",title:"Superior Vena Cava Syndrome",timeToAction:"24 hours",category:"Obstructive",symptoms:["Facial swelling (especially in morning)","Neck distention","Difficulty breathing/dyspnea","Upper extremity swelling","Dilated neck or chest wall veins","Cough, hoarseness, dysphagia"],diagnostics:["CT of chest with contrast","Venography if diagnosis uncertain","Consider bronchoscopy or mediastinoscopy for tissue diagnosis","Oxygen saturation monitoring"],management:[{title:"Airway Management",description:"Elevate head of bed; supplemental oxygen if needed"},{title:"Radiation Therapy",description:"For known malignancies, especially radiosensitive tumors"},{title:"Stent Placement",description:"Consider urgent stenting for severe symptoms"},{title:"Tissue Diagnosis",description:"Obtain if not previously established (guides definitive treatment)"}],medications:[{name:"Dexamethasone",dosage:"4-10mg IV every 6 hours"},{name:"Furosemide",dosage:"20-40mg IV/PO daily as needed for edema"}]},{id:"hypercalcemia-of-malignancy",title:"Hypercalcemia of Malignancy",timeToAction:"24 hours",category:"Metabolic",symptoms:["Altered mental status, confusion","Nausea, vomiting, constipation","Polydipsia, polyuria","Weakness, fatigue","Cardiac arrhythmias","Bone pain"],diagnostics:["Serum calcium (total and ionized)","Kidney function tests","Serum phosphorus, magnesium","PTH and PTHrP levels","25-OH Vitamin D"],management:[{title:"Volume Expansion",description:"Normal saline at 200-300 mL/hr initially, then maintenance"},{title:"Calciuresis",description:"Loop diuretics after adequate hydration"},{title:"Bisphosphonate Therapy",description:"For moderate to severe hypercalcemia (> 12 mg/dL)"},{title:"Treat Underlying Malignancy",description:"Definitive treatment based on primary tumor"}],medications:[{name:"Zoledronic Acid",dosage:"4mg IV over 15 minutes"},{name:"Pamidronate",dosage:"60-90mg IV over 2-4 hours"},{name:"Furosemide",dosage:"20-40mg IV after hydration"},{name:"Calcitonin",dosage:"4-8 IU/kg SC/IM every 12 hours (short-term use)"}],additionalNotes:"Response to bisphosphonates typically occurs in 2-4 days; monitor calcium levels daily."},{id:"febrile-neutropenia",title:"Febrile Neutropenia",timeToAction:"60 minutes",category:["Hematologic","Infectious"],symptoms:["Fever (â‰¥38.3Â°C once or â‰¥38.0Â°C for â‰¥1h)","Absolute neutrophil count <500 cells/mmÂ³","Shaking chills","Hypotension","Mucositis","Localizing symptoms of infection"],diagnostics:["Complete blood count with differential","Blood cultures (â‰¥2 sets)","Urinalysis and urine culture","Chest radiograph","Cultures from any suspected sites of infection"],management:[{title:"Empiric Antibiotics",description:"Start broad-spectrum antibiotics within 1 hour of presentation"},{title:"Risk Stratification",description:"MASCC or CISNE score to determine inpatient vs. outpatient management"},{title:"Infection Site Assessment",description:"Comprehensive evaluation for source of infection"},{title:"G-CSF Consideration",description:"Consider for high-risk patients or expected prolonged neutropenia"}],medications:[{name:"Cefepime",dosage:"2g IV every 8 hours"},{name:"Piperacillin-Tazobactam",dosage:"4.5g IV every 6-8 hours"},{name:"Meropenem",dosage:"1g IV every 8 hours"},{name:"Add Vancomycin",dosage:"15-20mg/kg IV every 8-12 hours if MRSA suspected"}],additionalNotes:"Reassess antibiotic therapy after 48 hours based on cultures and clinical response."},{id:"septic-shock",title:"Septic Shock in Cancer Patients",timeToAction:"30 minutes",category:"Infectious",symptoms:["Persistent hypotension after fluid resuscitation","Temperature >38.3Â°C or <36Â°C","Heart rate >90 beats/minute","Respiratory rate >20 breaths/minute or PaCO2 <32 mmHg","Altered mental status","Decreased urine output (<0.5 mL/kg/hr)","Mottled skin or prolonged capillary refill"],diagnostics:["Blood cultures (at least 2 sets)","CBC with differential","Comprehensive metabolic panel","Lactate level","Blood gases","Chest X-ray","Urinalysis and urine culture","Imaging of suspected infection sites"],management:[{title:"Immediate Fluid Resuscitation",description:"30 mL/kg crystalloid for hypotension or lactate â‰¥4 mmol/L within first 3 hours"},{title:"Broad-Spectrum Antibiotics",description:"Administer within 1 hour of recognition"},{title:"Vasopressors",description:"If hypotension persists despite fluid resuscitation"},{title:"Source Control",description:"Identify and control source of infection (drain abscesses, remove infected devices)"},{title:"ICU Transfer",description:"Arrange immediate transfer to intensive care"}],medications:[{name:"Norepinephrine",dosage:"First-line vasopressor, 0.1-0.5 mcg/kg/min IV"},{name:"Broad-spectrum antibiotics",dosage:"Per institutional protocol and suspected source"},{name:"Vasopressin",dosage:"May be added to norepinephrine (0.03-0.04 units/min)"}],additionalNotes:"Cancer patients are at higher risk for multidrug-resistant organisms; consider previous microbiology results and recent antibiotic exposure when selecting empiric therapy."},{id:"chemo-anaphylaxis",title:"Anaphylaxis from Chemotherapy",timeToAction:"5 minutes",category:"Treatment-Related",symptoms:["Hypotension","Wheezing or bronchospasm","Urticaria or flushing","Angioedema","Dyspnea","Gastrointestinal symptoms (nausea, vomiting, diarrhea)","Temporal relationship to chemotherapy infusion"],diagnostics:["Clinical diagnosis based on symptoms","Vital signs monitoring","Pulse oximetry","Consider tryptase level (if available, within 3 hours of reaction)"],management:[{title:"Stop Infusion",description:"Immediately discontinue the offending agent"},{title:"Maintain Airway",description:"Position patient, prepare for intubation if severe"},{title:"Epinephrine",description:"Administer IM epinephrine as first-line treatment"},{title:"Fluid Resuscitation",description:"IV fluids for hypotension"},{title:"Secondary Medications",description:"H1 and H2 antihistamines, corticosteroids"}],medications:[{name:"Epinephrine",dosage:"0.3-0.5 mg IM (1:1000 solution), may repeat every 5-15 minutes as needed"},{name:"Diphenhydramine",dosage:"25-50 mg IV/IM/PO"},{name:"Ranitidine or famotidine",dosage:"Ranitidine 50 mg IV or Famotidine 20 mg IV"},{name:"Methylprednisolone",dosage:"125 mg IV"}],additionalNotes:"Document reaction in detail; consider allergy/immunology consult for desensitization protocols if the chemotherapy agent is essential for treatment."},{id:"leukostasis",title:"Leukostasis in Acute Leukemia",timeToAction:"6 hours",category:"Hematologic",symptoms:["Dyspnea or hypoxemia","Confusion or altered mental status","Visual changes","Headache","Very high WBC count (>100,000/Î¼L, especially in AML)","Pulmonary infiltrates without infection","Priapism (rare)"],diagnostics:["Complete blood count with differential","Blood gas analysis","Chest X-ray","Brain imaging (if neurological symptoms)","Coagulation studies","Basic metabolic panel"],management:[{title:"Urgent Leukapheresis",description:"Particularly for symptomatic patients with WBC >100,000/Î¼L"},{title:"Hydration",description:"IV fluids to maintain good hydration and urine output"},{title:"Cytoreduction",description:"Hydroxyurea or other rapidly acting cytoreductive therapy"},{title:"Avoid Transfusions",description:"If possible, avoid RBC transfusions which may increase viscosity"},{title:"Allopurinol or Rasburicase",description:"Preemptive treatment for tumor lysis syndrome"}],medications:[{name:"Hydroxyurea",dosage:"50-100 mg/kg/day PO divided in 2-3 doses"},{name:"Rasburicase",dosage:"0.2 mg/kg IV once daily (for high risk of TLS)"},{name:"Allopurinol",dosage:"300-600 mg/day PO"}],additionalNotes:"Leukostasis is a medical emergency requiring prompt hematology consultation. If leukapheresis is not immediately available, cytoreduction with hydroxyurea should be initiated while arranging transfer to a center with apheresis capability."},{id:"bowel-obstruction",title:"Bowel Obstruction due to Tumor",timeToAction:"24 hours",category:"Obstructive",symptoms:["Abdominal pain","Nausea and vomiting","Absence of bowel movements or flatus","Abdominal distention","High-pitched or absent bowel sounds","History of intra-abdominal malignancy (especially colorectal, ovarian, gastric)"],diagnostics:["Abdominal X-ray (supine and upright)","CT abdomen with contrast (if not contraindicated)","Complete blood count","Comprehensive metabolic panel","Blood gas analysis if concern for ischemia"],management:[{title:"NPO Status",description:"Nothing by mouth"},{title:"Nasogastric Tube",description:"For decompression and symptom relief"},{title:"IV Fluids",description:"Correct fluid and electrolyte imbalances"},{title:"Surgical Consultation",description:"Evaluate for possible surgical intervention"},{title:"Pharmacological Management",description:"Antiemetics, pain control, consider octreotide for malignant bowel obstruction"}],medications:[{name:"Octreotide",dosage:"100-600 mcg/day SC or IV continuous infusion"},{name:"Dexamethasone",dosage:"8-20 mg/day IV"},{name:"Ondansetron",dosage:"4-8 mg IV every 8 hours"},{name:"Opioid analgesics",dosage:"Titrate to pain control"}],additionalNotes:"In patients with advanced cancer, consider goals of care discussions. For inoperable cases, palliative measures may be appropriate, including venting gastrostomy for symptom control."},{id:"siadh",title:"SIADH (Syndrome of Inappropriate ADH Secretion)",timeToAction:"12 hours",category:"Metabolic",symptoms:["Hyponatremia (Na <135 mEq/L)","Decreased serum osmolality (<275 mOsm/kg)","Inappropriate urine concentration (Uosm >100 mOsm/kg)","Euvolemia (no edema or dehydration)","Headache","Nausea and vomiting","Confusion or altered mental status","Seizures (in severe cases)"],diagnostics:["Serum sodium and osmolality","Urine sodium and osmolality","Serum cortisol and TSH (to rule out adrenal insufficiency and hypothyroidism)","Chest imaging (to identify SCLC or other pulmonary malignancies)","Brain imaging (for CNS malignancies)","Volume status assessment"],management:[{title:"Fluid Restriction",description:"800-1000 mL/day for mild to moderate hyponatremia"},{title:"Hypertonic Saline",description:"For severe hyponatremia (Na <120 mEq/L) or neurological symptoms"},{title:"Monitor Sodium Correction Rate",description:"Not to exceed 8-10 mEq/L in 24 hours to avoid osmotic demyelination syndrome"},{title:"Treat Underlying Malignancy",description:"Directed therapy for SCLC or other causative tumor"},{title:"Pharmacologic Therapy",description:"Consider salt tablets, loop diuretics, or vasopressin receptor antagonists"}],medications:[{name:"3% Sodium Chloride",dosage:"For severe symptoms: 100-150 mL IV over 10-20 minutes, may repeat; otherwise 0.5-1 mL/kg/hr"},{name:"Tolvaptan",dosage:"Start 15 mg daily, can increase to 30-60 mg daily"},{name:"Salt tablets",dosage:"1-2 g TID with meals"},{name:"Furosemide",dosage:"20-40 mg daily (with salt tablets)"}],additionalNotes:"SIADH is commonly associated with small cell lung cancer, CNS disorders, and certain medications. Monitor sodium levels closely during correction to prevent osmotic demyelination syndrome."},{id:"ici-toxicities",title:"Immune Checkpoint Inhibitor Toxicities",timeToAction:"24 hours",category:"Treatment-Related",symptoms:["Colitis: diarrhea, abdominal pain","Pneumonitis: dyspnea, cough, hypoxia","Hepatitis: elevated liver enzymes, jaundice","Endocrinopathies: fatigue, headache, hypophysitis, thyroid dysfunction","Dermatitis: rash, pruritus","Nephritis: elevated creatinine","Myocarditis: chest pain, arrhythmia, heart failure","Neurological: neuropathy, myasthenia gravis-like syndrome, encephalitis"],diagnostics:["System-specific laboratory tests (liver function, thyroid function, etc.)","Inflammatory markers (CRP, ESR)","Imaging appropriate to affected organ system","Consider specialist consultations based on affected organ","Tissue biopsy in selected cases"],management:[{title:"Grade-Based Management",description:"Severity determines whether to continue, hold, or permanently discontinue ICI"},{title:"Corticosteroids",description:"Cornerstone of management for grade 2 or higher toxicities"},{title:"Specialty Consultation",description:"Based on organ system involved (gastroenterology, pulmonology, etc.)"},{title:"Additional Immunosuppression",description:"For steroid-refractory cases (infliximab, mycophenolate mofetil, etc.)"},{title:"Hormone Replacement",description:"For endocrinopathies"}],medications:[{name:"Prednisone/Methylprednisolone",dosage:"Grade 2: 0.5-1 mg/kg/day; Grade 3-4: 1-2 mg/kg/day"},{name:"Infliximab",dosage:"5 mg/kg IV for steroid-refractory colitis"},{name:"Mycophenolate mofetil",dosage:"500-1000 mg BID for hepatitis not responding to steroids"},{name:"Hormone replacement",dosage:"As needed for specific endocrinopathies"}],additionalNotes:"Early recognition and prompt intervention are critical. Most irAEs occur within first 12 weeks of treatment but can present months after discontinuation. Multidisciplinary management with oncology and organ specialists is recommended."}],ye=i=>{const a=i.match(/(\d+)\s*(\w+)/);if(!a)return i;const[t,m,s]=a,n=parseInt(m,10);return s.startsWith("minute")?n<60?`${n}m`:`${Math.floor(n/60)}h ${n%60}m`:s.startsWith("hour")?`${n}h`:s.startsWith("day")?`${n}d`:i},q=({timeToAction:i})=>{const a=()=>{const n=i.match(/(\d+)\s*(minutes?|hours?|days?)/i);if(!n)return{bg:"bg-yellow-600",text:"text-white"};const d=parseInt(n[1],10),h=n[2].toLowerCase();let u=d;return h.startsWith("hour")&&(u=d*60),h.startsWith("day")&&(u=d*24*60),u<=15?{bg:"bg-red-600",text:"text-white"}:u<=60?{bg:"bg-orange-500",text:"text-white"}:u<=360?{bg:"bg-yellow-500",text:"text-white"}:{bg:"bg-blue-500",text:"text-white"}},{bg:t,text:m}=a(),s=ye(i);return e.jsxs(b.div,{initial:{scale:.9,opacity:0},animate:{scale:1,opacity:1},className:`inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium ${t} ${m}`,whileHover:{scale:1.05},children:[e.jsx("svg",{className:"w-3 h-3 mr-1",fill:"currentColor",viewBox:"0 0 20 20",children:e.jsx("path",{fillRule:"evenodd",d:"M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z",clipRule:"evenodd"})}),"Act within ",s]})},xe=({protocol:i,onViewDetails:a})=>{const[t,m]=c.useState(!1),s=()=>(Array.isArray(i.category)?i.category:[i.category]).map(d=>e.jsx("span",{className:"inline-flex items-center px-2 py-0.5 rounded text-xs font-medium bg-blue-100 text-blue-800 mr-2",children:d},d));return e.jsxs("div",{className:"border border-gray-200 rounded-lg overflow-hidden bg-white shadow-sm hover:shadow-md transition-shadow",children:[e.jsxs("button",{className:"w-full flex justify-between items-center p-4 text-left focus:outline-none",onClick:()=>m(!t),children:[e.jsxs("div",{className:"flex flex-col sm:flex-row sm:items-center space-y-2 sm:space-y-0 sm:space-x-3",children:[e.jsx("h3",{className:"text-lg font-semibold text-gray-800",children:i.title}),i.timeToAction&&e.jsx(q,{timeToAction:i.timeToAction})]}),e.jsx(b.div,{animate:{rotate:t?180:0},transition:{duration:.2},children:e.jsx(ee,{className:"text-gray-500"})})]}),e.jsx("div",{className:"px-4 pb-3 border-t border-gray-100",children:e.jsxs("div",{className:"flex flex-wrap items-center gap-2 text-sm text-gray-600",children:[s(),e.jsxs("span",{className:"truncate",children:["Key signs: ",i.symptoms.slice(0,2).join(", "),i.symptoms.length>2&&"..."]})]})}),e.jsx(P,{children:t&&e.jsx(b.div,{initial:{height:0,opacity:0},animate:{height:"auto",opacity:1},exit:{height:0,opacity:0},transition:{duration:.2},className:"overflow-hidden",children:e.jsxs("div",{className:"p-4 border-t border-gray-100 bg-gray-50",children:[e.jsxs("div",{className:"mb-4",children:[e.jsx("h4",{className:"font-medium text-gray-700 mb-1",children:"Key Symptoms"}),e.jsxs("ul",{className:"list-disc list-inside space-y-1 text-gray-600",children:[i.symptoms.slice(0,3).map((n,d)=>e.jsx("li",{className:"text-sm",children:n},d)),i.symptoms.length>3&&e.jsxs("li",{className:"text-sm text-gray-500",children:["+ ",i.symptoms.length-3," more symptoms"]})]})]}),e.jsxs("div",{className:"mb-4",children:[e.jsx("h4",{className:"font-medium text-gray-700 mb-1",children:"Initial Management"}),e.jsxs("ul",{className:"list-disc list-inside space-y-1 text-gray-600",children:[i.management.slice(0,2).map((n,d)=>e.jsx("li",{className:"text-sm",children:n.title},d)),i.management.length>2&&e.jsxs("li",{className:"text-sm text-gray-500",children:["+ ",i.management.length-2," more steps"]})]})]}),e.jsxs("button",{onClick:n=>{n.stopPropagation(),a()},className:"mt-2 inline-flex items-center px-3 py-2 border border-red-300 text-sm leading-4 font-medium rounded-md text-red-700 bg-white hover:bg-red-50 focus:outline-none focus:ring-2 focus:ring-offset-2 focus:ring-red-500",children:["Full Protocol ",e.jsx(te,{className:"ml-2 h-3 w-3"})]})]})})})]})},be=({protocol:i,onClose:a})=>{const t=c.useRef(null),m=ie.useReactToPrint({content:()=>t.current});return e.jsx(b.div,{className:"fixed inset-0 bg-black bg-opacity-50 z-50 flex items-center justify-center p-4",initial:{opacity:0},animate:{opacity:1},exit:{opacity:0},onClick:a,children:e.jsxs(b.div,{className:"bg-white rounded-lg shadow-xl max-w-3xl w-full max-h-[90vh] overflow-auto",initial:{y:50,opacity:0},animate:{y:0,opacity:1},exit:{y:50,opacity:0},transition:{type:"spring",damping:25},onClick:s=>s.stopPropagation(),children:[e.jsxs("div",{className:"sticky top-0 bg-red-100 p-4 border-b border-red-200 flex justify-between items-center",children:[e.jsxs("div",{className:"flex items-center space-x-3",children:[e.jsx("h2",{className:"text-2xl font-bold text-red-800",children:i.title}),i.timeToAction&&e.jsx(q,{timeToAction:i.timeToAction})]}),e.jsxs("div",{className:"flex space-x-2",children:[e.jsx("button",{onClick:m,className:"p-2 bg-blue-100 text-blue-800 rounded-full hover:bg-blue-200","aria-label":"Print protocol",children:e.jsx("svg",{xmlns:"http://www.w3.org/2000/svg",className:"w-5 h-5",viewBox:"0 0 512 512",children:e.jsx("path",{fill:"currentColor",d:"M448 192V77.25c0-8.49-3.37-16.62-9.37-22.63L393.37 9.37c-6-6-14.14-9.37-22.63-9.37H96C78.33 0 64 14.33 64 32v160c-35.35 0-64 28.65-64 64v112c0 8.84 7.16 16 16 16h48v96c0 17.67 14.33 32 32 32h320c17.67 0 32-14.33 32-32v-96h48c8.84 0 16-7.16 16-16V256c0-35.35-28.65-64-64-64zm-64 256H128v-96h256v96zm0-224H128V64h192v48c0 8.84 7.16 16 16 16h48v96zm48 72c-13.25 0-24-10.75-24-24 0-13.26 10.75-24 24-24s24 10.74 24 24c0 13.25-10.75 24-24 24z"})})}),e.jsx("button",{onClick:a,className:"p-2 bg-gray-100 text-gray-800 rounded-full hover:bg-gray-200","aria-label":"Close modal",children:e.jsx("svg",{xmlns:"http://www.w3.org/2000/svg",className:"w-5 h-5",viewBox:"0 0 352 512",children:e.jsx("path",{fill:"currentColor",d:"M242.72 256l100.07-100.07c12.28-12.28 12.28-32.19 0-44.48l-22.24-22.24c-12.28-12.28-32.19-12.28-44.48 0L176 189.28 75.93 89.21c-12.28-12.28-32.19-12.28-44.48 0L9.21 111.45c-12.28 12.28-12.28 32.19 0 44.48L109.28 256 9.21 356.07c-12.28 12.28-12.28 32.19 0 44.48l22.24 22.24c12.28 12.28 32.2 12.28 44.48 0L176 322.72l100.07 100.07c12.28 12.28 32.2 12.28 44.48 0l22.24-22.24c12.28-12.28 12.28-32.19 0-44.48L242.72 256z"})})})]})]}),e.jsxs("div",{ref:t,className:"p-6 print:p-4",children:[e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6 print:gap-4",children:[e.jsxs("div",{children:[e.jsx("h3",{className:"text-xl font-semibold text-gray-800 mb-3",children:"Clinical Presentation"}),e.jsx("ul",{className:"list-disc ml-5 space-y-1 text-gray-700",children:i.symptoms.map((s,n)=>e.jsx("li",{children:s},n))}),e.jsx("h3",{className:"text-xl font-semibold text-gray-800 mt-6 mb-3",children:"Diagnostics"}),e.jsx("ul",{className:"list-disc ml-5 space-y-1 text-gray-700",children:i.diagnostics.map((s,n)=>e.jsx("li",{children:s},n))})]}),e.jsxs("div",{children:[e.jsx("h3",{className:"text-xl font-semibold text-gray-800 mb-3",children:"Management"}),e.jsx("ol",{className:"list-decimal ml-5 space-y-2 text-gray-700",children:i.management.map((s,n)=>e.jsxs("li",{className:"pl-1",children:[e.jsx("div",{className:"font-medium",children:s.title}),e.jsx("div",{className:"text-sm mt-1",children:s.description})]},n))}),i.medications&&e.jsxs(e.Fragment,{children:[e.jsx("h3",{className:"text-xl font-semibold text-gray-800 mt-6 mb-3",children:"Medications"}),e.jsx("div",{className:"border-t border-b border-gray-200",children:i.medications.map((s,n)=>e.jsxs("div",{className:`py-2 px-3 ${n%2===0?"bg-gray-50":"bg-white"}`,children:[e.jsx("div",{className:"font-medium",children:s.name}),e.jsx("div",{className:"text-sm text-gray-600",children:s.dosage})]},n))})]})]})]}),i.additionalNotes&&e.jsxs("div",{className:"mt-6 p-4 bg-yellow-50 border border-yellow-200 rounded",children:[e.jsx("h3",{className:"font-semibold text-yellow-800 mb-2",children:"Additional Notes"}),e.jsx("p",{className:"text-yellow-800",children:i.additionalNotes})]})]})]})})},fe=["All","Hematologic","Metabolic","Treatment-Related","Obstructive","Infectious"],ve=["All","Critical","Non-urgent"],Ce=()=>{const[i,a]=c.useState(""),[t,m]=c.useState(null),[s,n]=c.useState("All"),[d,h]=c.useState("All"),u=(r,g)=>g==="All"?!0:Array.isArray(r.category)?r.category.includes(g):r.category===g,o=r=>{if(!r.timeToAction)return"Non-urgent";const g=r.timeToAction.match(/(\d+)\s*(minutes?|hours?|days?)/i);if(!g)return"Non-urgent";const C=parseInt(g[1],10),I=g[2].toLowerCase();let v=C;return I.startsWith("hour")&&(v=C*60),I.startsWith("day")&&(v=C*60*24),v<=60?"Critical":v>720?"Non-urgent":"All"},p=c.useMemo(()=>F.filter(r=>{const g=i.trim()===""||r.title.toLowerCase().includes(i.toLowerCase())||r.symptoms.some(v=>v.toLowerCase().includes(i.toLowerCase())),C=u(r,s),I=d==="All"||o(r)===d||d==="Critical"&&o(r)==="Critical";return g&&C&&I}),[i,s,d]),x=c.useMemo(()=>F.find(r=>r.id===t),[t]);return e.jsxs("div",{className:"p-4 md:p-6 space-y-4 md:space-y-6",children:[e.jsx("h2",{className:"text-2xl font-bold text-gray-800",children:"Emergency Protocols"}),e.jsxs("div",{className:"flex flex-col md:flex-row gap-4",children:[e.jsxs("div",{className:"relative flex-grow",children:[e.jsx("div",{className:"absolute inset-y-0 left-0 pl-3 flex items-center pointer-events-none",children:e.jsx(se,{className:"h-4 w-4 text-gray-400"})}),e.jsx("input",{type:"text",placeholder:"Search by name or symptom...",className:"pl-10 pr-4 py-2 w-full border border-gray-300 rounded-md focus:ring-2 focus:ring-red-500 focus:border-red-500",value:i,onChange:r=>a(r.target.value)})]}),e.jsx("div",{className:"flex-shrink-0",children:e.jsxs("div",{className:"relative",children:[e.jsx("select",{className:"pl-10 pr-4 py-2 border border-gray-300 rounded-md appearance-none focus:ring-2 focus:ring-red-500 focus:border-red-500",value:d,onChange:r=>h(r.target.value),children:ve.map(r=>e.jsx("option",{value:r,children:r==="All"?"All Urgencies":r},r))}),e.jsx("div",{className:"absolute inset-y-0 left-0 pl-3 flex items-center pointer-events-none",children:e.jsx(ae,{className:"h-4 w-4 text-gray-400"})})]})})]}),e.jsx("div",{className:"border-b border-gray-200",children:e.jsx("nav",{className:"-mb-px flex flex-wrap space-x-4 overflow-x-auto","aria-label":"Categories",children:fe.map(r=>e.jsx("button",{className:`whitespace-nowrap pb-2 font-medium text-sm border-b-2 ${s===r?"border-red-500 text-red-600":"border-transparent text-gray-500 hover:text-gray-700 hover:border-gray-300"}`,onClick:()=>n(r),children:r},r))})}),e.jsxs("div",{className:"space-y-3",children:[e.jsx(P,{children:p.map(r=>e.jsx(b.div,{initial:{opacity:0,y:20},animate:{opacity:1,y:0},exit:{opacity:0,height:0},transition:{duration:.2},children:e.jsx(xe,{protocol:r,onViewDetails:()=>m(r.id)})},r.id))}),p.length===0&&e.jsx("div",{className:"text-center py-10",children:e.jsx("p",{className:"text-gray-500",children:"No emergency protocols found matching your criteria"})})]}),e.jsx(P,{children:x&&e.jsx(be,{protocol:x,onClose:()=>m(null)})})]})},V=[{key:"breast",label:"Breast Cancer"},{key:"lung",label:"Lung Cancer"},{key:"lymphoma",label:"Lymphoma"},{key:"colorectal",label:"Colorectal Cancer"},{key:"gastric",label:"Gastric Cancer"},{key:"pancreatic",label:"Pancreatic Cancer"},{key:"ovarian",label:"Ovarian Cancer"},{key:"cervical",label:"Cervical Cancer"},{key:"renal",label:"Renal Cell Carcinoma"},{key:"prostate",label:"Prostate Cancer"},{key:"head_neck",label:"Head & Neck Cancer"},{key:"bladder",label:"Bladder Cancer"},{key:"multiple_myeloma",label:"Multiple Myeloma"}];function Ne(i){switch(i){case"colorectal":return["CBC","BMP","CT Abdomen","Consent","Isolation if febrile"];case"gastric":return["CBC","CMP","Endoscopy Report","Nutrition Consult"];case"pancreatic":return["LFTs","CT Abdomen","Hydration Orders","Pain Team Consult"];case"ovarian":return["Pelvic US/CT","Ascitic Tap if needed","CBC","Consent"];case"multiple_myeloma":return["CBC","CMP","Calcium","Renal Panel","SPEP"];default:return["CBC","CMP","Consent","Vitals","Isolation if needed"]}}function je(i,a){const t=["CBC","CMP","IV Fluids","Vitals Q4H"];return a==="GI Bleeding"?[...t,"Type & Cross","IV PPI","NPO","GI Consult"]:a==="Obstructive Jaundice"?[...t,"LFTs","ERCP/Intervention Referral","Hydration"]:a==="Spinal Cord Compression"?[...t,"MRI Spine","IV Steroids (Dexamethasone)","Neuro Consult"]:a==="Febrile Neutropenia"?[...t,"Blood Cultures","Start Broad-Spectrum Antibiotics","Monitor Temperature Q2H"]:t}const we=ue,ke=pe,X=c.forwardRef(({className:i,children:a,...t},m)=>e.jsxs(O,{ref:m,className:f("flex h-10 w-full items-center justify-between rounded-md border border-input bg-background px-3 py-2 text-sm ring-offset-background placeholder:text-muted-foreground focus:outline-none focus:ring-2 focus:ring-ring focus:ring-offset-2 disabled:cursor-not-allowed disabled:opacity-50",i),...t,children:[a,e.jsx(re,{asChild:!0,children:e.jsx(oe,{className:"h-4 w-4 opacity-50"})})]}));X.displayName=O.displayName;const Q=c.forwardRef(({className:i,children:a,position:t="popper",...m},s)=>e.jsx(le,{children:e.jsx(E,{ref:s,className:f("relative z-50 min-w-[8rem] overflow-hidden rounded-md border bg-popover text-popover-foreground shadow-md data-[state=open]:animate-in data-[state=closed]:animate-out data-[state=closed]:fade-out-0 data-[state=open]:fade-in-0 data-[state=closed]:zoom-out-95 data-[state=open]:zoom-in-95 data-[side=bottom]:slide-in-from-top-2 data-[side=left]:slide-in-from-right-2 data-[side=right]:slide-in-from-left-2 data-[side=top]:slide-in-from-bottom-2",t==="popper"&&"data-[side=bottom]:translate-y-1 data-[side=left]:-translate-x-1 data-[side=right]:translate-x-1 data-[side=top]:-translate-y-1",i),position:t,...m,children:e.jsx(ce,{className:f("p-1",t==="popper"&&"h-[var(--radix-select-trigger-height)] w-full min-w-[var(--radix-select-trigger-width)]"),children:a})})}));Q.displayName=E.displayName;const Se=c.forwardRef(({className:i,...a},t)=>e.jsx($,{ref:t,className:f("py-1.5 pl-8 pr-2 text-sm font-semibold",i),...a}));Se.displayName=$.displayName;const J=c.forwardRef(({className:i,children:a,...t},m)=>e.jsxs(U,{ref:m,className:f("relative flex w-full cursor-default select-none items-center rounded-sm py-1.5 pl-8 pr-2 text-sm outline-none focus:bg-accent focus:text-accent-foreground data-[disabled]:pointer-events-none data-[disabled]:opacity-50",i),...t,children:[e.jsx("span",{className:"absolute left-2 flex h-3.5 w-3.5 items-center justify-center",children:e.jsx(de,{children:e.jsx(z,{className:"h-4 w-4"})})}),e.jsx(me,{children:a})]}));J.displayName=U.displayName;const Ie=c.forwardRef(({className:i,...a},t)=>e.jsx(G,{ref:t,className:f("-mx-1 my-1 h-px bg-muted",i),...a}));Ie.displayName=G.displayName;const H=c.forwardRef(({className:i,...a},t)=>e.jsx(W,{ref:t,className:f("peer h-4 w-4 shrink-0 rounded-sm border border-primary ring-offset-background focus-visible:outline-none focus-visible:ring-2 focus-visible:ring-ring focus-visible:ring-offset-2 disabled:cursor-not-allowed disabled:opacity-50 data-[state=checked]:bg-primary data-[state=checked]:text-primary-foreground",i),...a,children:e.jsx(he,{className:f("flex items-center justify-center text-current"),children:e.jsx(z,{className:"h-4 w-4"})})}));H.displayName=W.displayName;const B=c.forwardRef(({className:i,...a},t)=>e.jsx("textarea",{className:f("flex min-h-[80px] w-full rounded-md border border-input bg-background px-3 py-2 text-sm ring-offset-background placeholder:text-muted-foreground focus-visible:outline-none focus-visible:ring-2 focus-visible:ring-ring focus-visible:ring-offset-2 disabled:cursor-not-allowed disabled:opacity-50",i),ref:t,...a}));B.displayName="Textarea";const K=[{key:"febrile_neutropenia",label:"Febrile Neutropenia",isUrgent:!0},{key:"pain",label:"Uncontrolled Pain"},{key:"nausea_vomiting",label:"Intractable Nausea/Vomiting"},{key:"sob",label:"Shortness of Breath"},{key:"ams",label:"Altered Mental Status",isUrgent:!0},{key:"cord_compression",label:"Suspected Cord Compression",isUrgent:!0},{key:"svcs",label:"Suspected SVCS",isUrgent:!0},{key:"hypercalcemia",label:"Hypercalcemia",isUrgent:!0},{key:"tls",label:"Tumor Lysis Syndrome Risk",isUrgent:!0}],Ae=(i,a)=>["cord_compression","svcs","ams","hypercalcemia","tls"].includes(a)?{action:"Admit",urgency:"Critical"}:a==="febrile_neutropenia"?{action:"Admit",urgency:"High"}:["pain","nausea_vomiting","sob"].includes(a)?{action:"Admit",urgency:"Moderate"}:{action:"OPD",urgency:"Low"},Pe=(i,a,t)=>t.urgency==="Critical"||["cord_compression","svcs","ams"].includes(a)?{location:"ICU/Step-Down",reason:`Critical issue: ${a}`}:t.action==="Admit"?{location:"Oncology Ward",reason:`Admission required for ${a}`}:t.action==="OPD"?{location:"Outpatient Clinic Follow-up",reason:"Stable for outpatient management"}:{location:"Refer to ED/Specialist",reason:"Requires further evaluation or different service"},Te=(i,a,t,m,s)=>{var h,u;const n=((h=V.find(o=>o.key===i))==null?void 0:h.label)||i,d=((u=K.find(o=>o.key===a))==null?void 0:u.label)||a;return`
**Oncology Admission Note**

**Patient Presentation:** Patient with ${n} presents with ${d}.

**History of Present Illness (HPI):**
[Detailed HPI to be filled in by clinician]

**Reason for Admission:** ${d} requiring inpatient management. Triage assessment indicates ${t.action} with ${t.urgency} urgency.

**Initial Orders:**
${m.map(o=>`- ${o}`).join(`
`)}

**Plan & Disposition:**
- Admit to ${s.location}.
- Rationale: ${s.reason}.
- Consults: [Add consults as needed, e.g., Neurosurgery, Palliative Care]
- Follow-up: [Add follow-up plan]

**Code Status:** [Confirm code status]

[Clinician Name/Signature]
Date/Time: ${new Date().toLocaleString()}
  `.trim()},Me=()=>{const[i,a]=c.useState(1),[t,m]=c.useState(V[0].key),[s,n]=c.useState(null),[d,h]=c.useState({}),u=c.useMemo(()=>!t||!s?null:Ae(t,s),[t,s]),o=c.useMemo(()=>Ne(t),[t]),p=c.useMemo(()=>o.length===0?!0:o.every(l=>d[l]),[o,d]),x=c.useMemo(()=>!t||!s?[]:je(t,s),[t,s]),r=c.useMemo(()=>!t||!s||!u?null:Pe(t,s,u),[t,s,u]),g=c.useMemo(()=>!t||!s||!u||!r?"":Te(t,s,u,x,r),[t,s,u,x,r]),C=c.useCallback((l,N)=>{h(Y=>({...Y,[l]:N}))},[]);c.useCallback(l=>e.jsx(y,{variant:s===l.key?"default":"outline",size:"sm",className:"rounded-lg px-4 py-2 font-semibold border shadow-sm hover:bg-blue-600 hover:text-white transition-all duration-200",onClick:()=>n(l.key),children:e.jsxs("span",{className:"flex items-center gap-2",children:[l.label,l.isUrgent&&e.jsx(T,{className:"inline-block w-4 h-4 text-amber-500"})]})},l.key),[s]);const I=l=>{switch(l){case"Critical":return"bg-red-600";case"High":return"bg-orange-500";case"Moderate":return"bg-yellow-400 text-black";case"Low":return"bg-green-500";default:return"bg-gray-400"}},v=c.useCallback(()=>{window.print()},[]),M=c.useCallback(()=>{a(l=>Math.min(l+1,5))},[]),D=c.useCallback(()=>{a(l=>Math.max(l-1,1))},[]),Z=[{label:"Cancer Type",icon:"ðŸ¥"},{label:"Issue",icon:"âš ï¸"},{label:"Checklist",icon:"ðŸ“‹"},{label:"Note",icon:"ðŸ“"}];return e.jsxs("div",{className:"space-y-6 p-4 max-w-7xl mx-auto",children:[e.jsx("div",{className:"flex justify-between items-center px-6 py-3 bg-slate-50 rounded-xl shadow-sm text-sm font-medium text-gray-600 mb-6",children:Z.map((l,N)=>e.jsxs("div",{className:`flex items-center gap-2 px-3 py-2 rounded transition-all ${i===N+1?"text-blue-700 font-bold border-b-2 border-blue-600":"hover:text-blue-500"}`,children:[e.jsx("span",{children:l.icon}),e.jsxs("span",{children:["Step ",N+1,": ",l.label]})]},N))}),e.jsxs(P,{mode:"wait",children:[i===1&&e.jsx(b.div,{initial:{opacity:0,y:20},animate:{opacity:1,y:0},exit:{opacity:0,y:-20},className:"transition-all duration-200",children:e.jsxs(j,{className:"rounded-xl border border-slate-200 shadow-lg bg-white",children:[e.jsx(w,{className:"pb-2",children:e.jsx(k,{className:"text-xl text-blue-900",children:"Select Cancer Type"})}),e.jsxs(S,{className:"pt-4",children:[e.jsxs(we,{value:t,onValueChange:m,children:[e.jsx(X,{className:"w-full border-slate-200 rounded-lg relative z-10",children:e.jsx(ke,{})}),e.jsx(Q,{className:"absolute z-50 bg-white border shadow-md rounded-md mt-1 w-full max-w-xs min-w-[280px] whitespace-normal overflow-x-hidden overflow-y-auto max-h-72",side:"bottom",children:V.map(l=>e.jsx(J,{value:l.key,className:"whitespace-normal px-3 py-2 text-sm",children:l.label},l.key))})]}),e.jsx("div",{className:"mt-6 flex justify-end",children:e.jsx(y,{onClick:M,className:"bg-blue-600 hover:bg-blue-700 text-white px-6",children:"Next"})})]})]})}),i===2&&e.jsx(b.div,{initial:{opacity:0,y:20},animate:{opacity:1,y:0},exit:{opacity:0,y:-20},children:e.jsxs(j,{className:"rounded-xl border border-slate-200 shadow-lg bg-white",children:[e.jsx(w,{className:"pb-2",children:e.jsx(k,{className:"text-xl text-blue-900",children:"Select Presenting Issue"})}),e.jsxs(S,{className:"pt-4",children:[e.jsx("div",{className:"grid grid-cols-2 gap-3",children:K.map(l=>e.jsx(y,{variant:s===l.key?"default":"outline",size:"sm",className:`rounded-lg px-4 py-3 font-medium border hover:shadow-md transition duration-150 ${s===l.key?"bg-blue-700 text-white shadow-blue-100":"bg-white hover:bg-blue-50"}`,onClick:()=>n(l.key),children:e.jsxs("span",{className:"flex items-center gap-2",children:[l.label,l.isUrgent&&e.jsx(T,{className:"w-4 h-4 text-amber-500"})]})},l.key))}),e.jsxs("div",{className:"mt-6 flex justify-between",children:[e.jsx(y,{variant:"outline",onClick:D,children:"Back"}),e.jsx(y,{onClick:M,disabled:!s,className:"bg-blue-600 hover:bg-blue-700 text-white px-6",children:"Next"})]})]})]})}),i===3&&u&&e.jsx(b.div,{initial:{opacity:0,y:20},animate:{opacity:1,y:0},exit:{opacity:0,y:-20},children:e.jsxs(j,{className:"rounded-xl border border-slate-200 shadow-lg bg-white",children:[e.jsx(w,{className:"pb-2",children:e.jsx(k,{className:"text-xl text-blue-900",children:"Pre-Admission Checklist"})}),e.jsxs(S,{children:[e.jsx("div",{className:"mb-6",children:e.jsxs(R,{className:`px-4 py-1.5 rounded-full text-white font-medium ${I(u.urgency)}`,children:["ðŸš¨ ",u.urgency," Priority"]})}),e.jsx("div",{className:"space-y-2 max-h-[400px] overflow-y-auto pr-2",children:o.map(l=>e.jsxs("div",{className:"flex items-center gap-3 p-2.5 rounded hover:bg-slate-50 transition-colors",children:[e.jsx(H,{checked:d[l]||!1,onCheckedChange:N=>C(l,N),className:"border-2 border-slate-300"}),e.jsx("span",{className:"text-sm text-slate-700",children:l})]},l))}),e.jsxs("div",{className:"mt-6 flex justify-between",children:[e.jsx(y,{variant:"outline",onClick:D,children:"Back"}),e.jsx(y,{onClick:M,disabled:!p,className:"bg-blue-600 hover:bg-blue-700 text-white px-6",children:"Next"})]})]})]})}),i===4&&u&&r&&e.jsx(b.div,{initial:{opacity:0,y:20},animate:{opacity:1,y:0},exit:{opacity:0,y:-20},children:e.jsxs(j,{className:"rounded-xl border border-slate-200 shadow-lg bg-white",children:[e.jsx(w,{className:"pb-2",children:e.jsx(k,{className:"text-xl text-blue-900",children:"Admission Note"})}),e.jsxs(S,{children:[e.jsx(B,{value:g,className:"h-[30rem] font-mono text-sm bg-slate-50 border border-slate-200 rounded-lg p-4",readOnly:!0}),e.jsxs("div",{className:"mt-6 flex justify-between",children:[e.jsx(y,{variant:"outline",onClick:D,children:"Back"}),e.jsxs(y,{onClick:v,className:"bg-blue-600 hover:bg-blue-700 text-white px-6",children:[e.jsx(_,{className:"mr-2 h-4 w-4"}),"Print Note"]})]})]})]})})]})]})},De=()=>e.jsxs("div",{className:"p-6 space-y-6",children:[e.jsx("h2",{className:"text-2xl font-bold text-gray-800",children:"Supportive Care"}),e.jsxs("div",{className:"grid gap-4",children:[e.jsxs("div",{className:"p-4 bg-green-50 border border-green-200 rounded-lg",children:[e.jsx("h3",{className:"text-xl font-semibold text-green-800 mb-2",children:"Pain Management"}),e.jsx("p",{className:"text-green-700",children:"Pain management protocols will be added here."})]}),e.jsxs("div",{className:"p-4 bg-green-50 border border-green-200 rounded-lg",children:[e.jsx("h3",{className:"text-xl font-semibold text-green-800 mb-2",children:"Nutritional Support"}),e.jsx("p",{className:"text-green-700",children:"Nutritional support guidelines will be added here."})]}),e.jsxs("div",{className:"p-4 bg-green-50 border border-green-200 rounded-lg",children:[e.jsx("h3",{className:"text-xl font-semibold text-green-800 mb-2",children:"Psychological Support"}),e.jsx("p",{className:"text-green-700",children:"Psychological support resources will be added here."})]})]})]}),L=["Afebrile > 24 hrs","Oral intake adequate","Pain controlled","Labs stable (Hb, WBC, Ca)","Performance status acceptable (ECOG â‰¤ 2)","Caregiver plan ready"],Le=()=>{const[i,a]=c.useState({}),[t,m]=c.useState({diagnosis:"",hospitalCourse:"",medications:"",followUp:"",redFlags:"",consultantNotes:"",contactInfo:"",neutrophilCount:0,nextAppointmentDate:""}),s=(o,p)=>a(x=>({...x,[o]:p})),n=L.every(o=>i[o]),d=t.neutrophilCount<1.5,h=()=>{const o=new Date(t.nextAppointmentDate),p=new Date;return(o.getTime()-p.getTime())/(1e3*60*60*24)>7},u=()=>["ðŸ“‹ Oncology Discharge Summary",`Date: ${new Date().toLocaleDateString()}`,"","âœ… Checklist:",...L.map(o=>`- [${i[o]?"x":" "}] ${o}`),"","ðŸ“ Clinical Details:",`Diagnosis: ${t.diagnosis}`,`Hospital Course: ${t.hospitalCourse}`,`Medications: ${t.medications}`,`Follow-up: ${t.followUp}`,`Red Flags: ${t.redFlags}`,`Consultant Notes: ${t.consultantNotes}`,`Contact Info: ${t.contactInfo}`].join(`
`);return e.jsxs("div",{className:"max-w-5xl mx-auto px-6 py-8 space-y-6",children:[e.jsx("h1",{className:"text-2xl font-bold text-blue-900",children:"Oncology Discharge Assistant"}),e.jsxs(j,{className:"shadow border-blue-200",children:[e.jsx(w,{className:"bg-blue-50 border-b",children:e.jsx(k,{className:"text-blue-800 text-lg font-semibold",children:"Step 1: Discharge Eligibility"})}),e.jsxs(S,{className:"grid grid-cols-1 sm:grid-cols-2 gap-4 p-4",children:[L.map(o=>e.jsxs("div",{className:"flex items-center gap-2",children:[e.jsx(H,{checked:!!i[o],onCheckedChange:p=>s(o,p)}),e.jsx("span",{children:o})]},o)),e.jsx("div",{className:"col-span-full",children:e.jsx(R,{variant:n?"default":"destructive",children:n?"âœ… Discharge Ready":"â— Incomplete Checklist"})})]})]}),e.jsxs(j,{className:"shadow border-blue-200",children:[e.jsx(w,{className:"bg-blue-50 border-b",children:e.jsx(k,{className:"text-blue-800 text-lg font-semibold",children:"Step 2: Clinical Discharge Details"})}),e.jsxs(S,{className:"space-y-4 p-4",children:[d&&e.jsxs(R,{variant:"destructive",className:"flex items-center gap-2",children:[e.jsx(T,{className:"w-4 h-4"}),"Neutropenic Alert"]}),h()&&e.jsxs("div",{className:"flex items-center gap-2 bg-yellow-100 text-yellow-800 border border-yellow-300 p-2 rounded",children:[e.jsx(T,{className:"w-4 h-4"}),e.jsx("span",{children:"Follow-up is more than 7 days"})]}),Object.entries(t).map(([o,p])=>o==="neutrophilCount"||o==="nextAppointmentDate"?null:e.jsxs("div",{className:"space-y-1",children:[e.jsx("label",{className:"block font-medium capitalize",children:o.replace(/([A-Z])/g," $1")}),e.jsx(B,{rows:3,value:p,onChange:x=>m(r=>({...r,[o]:x.target.value})),className:"w-full"})]},o)),e.jsxs("div",{className:"grid grid-cols-1 sm:grid-cols-2 gap-4",children:[e.jsxs("div",{children:[e.jsx("label",{className:"block font-medium",htmlFor:"neutrophil-count",children:"Neutrophil Count"}),e.jsx("input",{id:"neutrophil-count",type:"number",value:t.neutrophilCount,onChange:o=>m(p=>({...p,neutrophilCount:parseFloat(o.target.value)})),className:"w-full mt-1 p-2 border rounded"})]}),e.jsxs("div",{children:[e.jsx("label",{className:"block font-medium",htmlFor:"next-appointment",children:"Next Appointment"}),e.jsx("input",{id:"next-appointment",type:"date",value:t.nextAppointmentDate,onChange:o=>m(p=>({...p,nextAppointmentDate:o.target.value})),className:"w-full mt-1 p-2 border rounded"})]})]})]})]}),e.jsxs(j,{className:"shadow border-blue-200",children:[e.jsx(w,{className:"bg-blue-50 border-b",children:e.jsx(k,{className:"text-blue-800 text-lg font-semibold",children:"Step 3: Export Summary"})}),e.jsxs(S,{className:"space-y-4 p-4",children:[e.jsx("pre",{className:"whitespace-pre-wrap text-sm bg-gray-50 p-4 rounded border",children:u()}),e.jsxs("div",{className:"flex gap-2",children:[e.jsxs(y,{className:"flex gap-2 items-center",onClick:()=>window.print(),children:[e.jsx(_,{className:"w-4 h-4"}),"Print"]}),e.jsxs(y,{variant:"outline",className:"flex gap-2 items-center",children:[e.jsx(ge,{className:"w-4 h-4"}),"Export PDF"]})]})]})]})]})},Be=()=>{const[i,a]=c.useState(0),t=["Emergencies","Admissions","Supportive Care","Discharge"],m=s=>{switch(s){case 0:return e.jsx(Ce,{});case 1:return e.jsx(Me,{});case 2:return e.jsx(De,{});case 3:return e.jsx(Le,{});default:return null}};return e.jsx(ne,{moduleName:"Inpatient Oncology",children:e.jsxs("div",{className:"p-6 bg-gradient-to-br from-purple-50 via-indigo-50 to-teal-50 min-h-screen",children:[e.jsx("h1",{className:"text-3xl font-bold mb-6 text-indigo-700",children:"Inpatient Department"}),e.jsxs(A.Group,{selectedIndex:i,onChange:a,children:[e.jsx(A.List,{className:"flex space-x-4 border-b pb-3 mb-6",children:t.map((s,n)=>e.jsx(A,{className:({selected:d})=>`
                cursor-pointer py-2 px-4 rounded-lg shadow transition-all duration-300
                ${d?"bg-gradient-to-r from-indigo-500 to-teal-500 text-white":"bg-white text-gray-600 hover:text-indigo-500 hover:shadow-md"}
              `,children:s},n))}),e.jsx(A.Panels,{className:"bg-white rounded-lg shadow",children:t.map((s,n)=>e.jsx(A.Panel,{className:"focus:outline-none",children:m(n)},n))})]})]})})};export{H as C,Be as I,B as T};
//# sourceMappingURL=module-inpatient-B_qP0o7e.js.map
